Receptor binding assays characterize the interaction between peptides and their target receptors, providing essential data for drug discovery and development. This protocol covers binding assay methodologies, data analysis, and regulatory requirements for therapeutic peptide characterization.
Type Method Throughput Information Application Radioligand binding [³H] or [¹²⁵I] displacement Moderate Kd, Ki, Bmax Primary characterization Competition binding Cold ligand displacement High IC₅₀, Ki Screening Kinetic binding (SPR) Surface plasmon resonance Moderate kon, koff, KD Mechanistic studies Fluorescence polarization FP competition High IC₅₀, Ki High-throughput screening Cell-based binding Intact cell binding Low-moderate Functional affinity Physiological relevance Scatchard analysis Linear transformation Low Kd, Bmax Historical method
Material Specification Purpose Radioligand [¹²⁵I]-labeled peptide Tracer Receptor preparation Membrane homogenate or intact cells Target Binding buffer PBS + 0.1% BSA, pH 7.4 Incubation medium Non-specific binding control Excess cold ligand (100× Kd) Define NSB Separation method Filtration or centrifugation Bound/free separation Scintillation fluid For [³H] or Gamma counter for [¹²⁵I] Detection
Step Action Conditions Duration 1 Prepare receptor suspension 10–50 μg protein/mL On ice 2 Prepare radioligand concentrations 0.1–10× Kd (8–12 concentrations) — 3 Add radioligand to receptor 100 μL each — 4 Incubate 25°C or 37°C 1–2 hours 5 Separate bound/free Filtration (GF/C filters) — 6 Wash filters 3× 3 mL cold buffer — 7 Count radioactivity Scintillation/gamma counter — 8 Calculate parameters Non-linear regression —
Step Action Conditions Duration 1 Prepare receptor suspension 10–50 μg protein/mL On ice 2 Add radioligand Fixed concentration (Kd) — 3 Add cold ligand 10–12 concentrations (log dilution) — 4 Incubate 25°C or 37°C 1–2 hours 5 Separate bound/free Filtration or centrifugation — 6 Count radioactivity Scintillation/gamma counter — 7 Calculate IC₅₀, Ki Non-linear regression —
Parameter Formula Description Kd Concentration at 50% Bmax Equilibrium dissociation constant Bmax Maximum specific binding Receptor density NSB Non-specific binding (at high cold ligand) Background binding Specific binding Total binding - NSB Receptor-mediated binding
Bound/Free = (Bmax - Bound) / Kd
Plot: Bound/Free vs. Bound → Linear slope = -1/Kd, y-intercept = Bmax/Kd
Parameter Formula Description IC₅₀ Concentration at 50% inhibition Inhibitory concentration Ki IC₅₀ / (1 + [Radioligand]/Kd) Cheng-Prusoff equation Hill coefficient Hill slope Cooperativity indicator
Parameter Setting Notes Instrument Biacore T200, Octet, etc. Label-free detection Chip CM5, SA, or NTA Based on immobilization strategy Immobilization Amine coupling, His-tag, Biotin Target receptor Flow rate 10–30 μL/min Minimize mass transport Temperature 25°C or 37°C Physiological conditions
Step Action Conditions Duration 1 Condition chip 3× 10 mM glycine pH 2.0 — 2 Immobilize receptor Amine coupling (10–50 RU) 10–20 min 3 Block excess 1 M ethanolamine 7 min 4 Establish baseline Running buffer 5 min 5 Inject analyte (peptide) 5–6 concentrations (2-fold dilution) 3 min association 6 Dissociation phase Running buffer 10–30 min 7 Regenerate 10 mM glycine pH 2.0 30 sec 8 Repeat for each concentration — —
Parameter Description Calculation kon Association rate constant kobs vs. concentration plot koff Dissociation rate constant Mono-exponential fit KD Equilibrium dissociation constant koff/kon Response (RU) Binding level Sensorgram height
Parameter Setting Notes Instrument Plate reader with FP 485 nm excitation, 528 nm emission Fluorophore Fluorescein, BODIPY On peptide ligand Peptide concentration 0.5–5 nM (tracer) Below Kd Receptor concentration 0.1–10× Kd Optimize for Z-factor Buffer PBS + 0.01% Tween-20 Reduce non-specific binding
Step Action Conditions Duration 1 Prepare tracer Fluorescein-peptide (0.5–5 nM) — 2 Prepare receptor Membrane suspension (1–10 μg/mL) — 3 Prepare competitor 10–12 concentrations (log dilution) — 4 Mix tracer + receptor + competitor 50 μL total volume — 5 Incubate 25°C or 37°C 1–2 hours 6 Read FP 485/528 nm — 7 Calculate IC₅₀ Non-linear regression —
Parameter Formula Description mP Millipolarization units (S - G×P)/(S + G×P) × 1000 Z-factor Assay quality 1 - 3(σp + σf)/(μp - μf) IC₅₀ Inhibition midpoint Non-linear fit
Step Action Conditions Duration 1 Culture cells expressing receptor Confluent monolayer 24–48 hours 2 Wash cells PBS + 0.1% BSA 3× 3 Add radioligand [¹²⁵I]-peptide (Kd) — 4 Add competitor (cold ligand) 10–12 concentrations — 5 Incubate 4°C (prevent internalization) 2–4 hours 6 Wash cells Cold PBS 3× 7 Lyse cells 0.1M NaOH 10 min 8 Count radioactivity Gamma counter —
Step Action Conditions Duration 1 Culture cells Confluent monolayer 24–48 hours 2 Add radioligand [¹²⁵I]-peptide (Kd) — 3 Incubate at 37°C Allow internalization 0–60 min 4 Wash with acid (pH 2.0) Remove surface-bound ligand 5 min 5 Lyse cells 0.1M NaOH 10 min 6 Count radioactivity Gamma counter — 7 Calculate internalized fraction Acid-resistant / total binding —
Receptor Purpose Concentration Range Target receptor Primary characterization 0.1–1000 nM Closely related receptors Selectivity assessment 0.1–1000 nM Off-target receptors Safety screening 1–1000 nM Kinase panel Specificity screening 1–1000 nM
Selectivity ratio = Ki (off-target) / Ki (target)
Ratio Interpretation Example >100 Highly selective Excellent 10–100 Selective Good 1–10 Moderately selective Acceptable <1 Non-selective Poor
Software Application Platform Prism Binding curve fitting Desktop Scrubber SPR data analysis Desktop Biacore T200 Evaluation SPR kinetics Instrument ActivityBase High-throughput screening Enterprise GraphPad Statistical analysis Desktop
Requirement Description Documentation Binding characterization Kd, Ki, selectivity Binding report Functional correlation Binding vs. activity Correlation data Reference standard Comparator binding Comparative data Validation Method validation Validation report
Guideline Application Requirements ICH Q6B Specifications Binding characterization ICH Q2(R1) Validation Method validation ICH S6(R1) Biotechnology Safety pharmacology
Problem Possible Cause Solution High NSB Non-specific binding Increase BSA, use correct filter Low signal Insufficient receptor Increase receptor concentration Variable results Receptor degradation Use fresh membranes Poor curve fit Narrow concentration range Extend concentration range High background Incomplete washing Increase wash steps Low Z-factor High variability Optimize assay conditions
Bylund DB, Yamamura HI. “Methods for receptor binding.” In Methods in Neurosciences , Vol. 2, 1990.
Hulme EC, Birdsall NJM. “Strategy and tactics in receptor-binding studies.” In Receptor-Ligand Interactions , 1992.
Rich RL, Myszka DG. “Advances in surface plasmon resonance biosensor analysis.” Curr Opin Biotechnol 2000;11:54-61.
Fang Y, et al. “Label-free receptor binding assays.” Anal Biochem 2015;485:1-12.
Rojo N, et al. “Receptor binding assays for therapeutic peptides: methods and applications.” J Pharm Biomed Anal 2022;210:114567.
